Monocytes from HTLV-1-infected patients are unable to fully mature into dendritic cells

Blood

Volumn 117, Issue 2, 2011, Pages 489-499

  Nascimento, Clarissa Rodrigues ^a   Lima, Marco Antonio ^b   Serpa, Maria José De Andrada ^b   Espindola, Otávio ^b   Leite, Ana Claudia Celestino ^b   Echevarria Lima, Juliana ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CLINICAL ARTICLE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; MALE; MONOCYTE; PRIORITY JOURNAL;

EID: 78751536414     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-03-272690     Document Type: Article

References (50)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of patients with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77(12):7415-7419.
2. de Thé G, Bomford R. HTLV-I vaccine: why, how, for whom? AIDS Res Hum Retroviruses. 1993;9(5):381-386.
3. Araujo AQ, Andrada-Serpa MJ. Tropical spastic paraparesis/HTLV-I- associated myelopathy in Brazil. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1):S33-S37.
4. Takatsuki K, Uchiyama T, Ueshima Y, Hattor IT. Further clinical observations and cytogenetic and functional studies of leukemic cells. Jpn J Clin Oncol. 1979;9(2):312-324.
5. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet. 1985;2(8452):407-410. (Pubitemid 15231248)
6. Uchiyama T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997;15:15-37. (Pubitemid 27169273)
7. Leite AC, Silva MT, Alamy AH, et al. Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy. J Neurol. 2004;251(7):877-881.
8. Araujo AQ, Silva MT. The HTLV-1 neurological complex. Lancet Neurol. 2006;5(12):1068-1076.
9. Catovsky D, Greaves MF, Rose M, et al. Adult T-cell lymphoma-leukaemia in Blacks from the West Indies. Lancet. 1982;20(8273):639-643. (Pubitemid 12179932)
10. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol. 1990;64(11):5682-5687.
11. Prince HE, York J, Golding J, Owen SM, Lal RB. Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production. Clin Diagn Lab Immunol. 1994;1(3):273-282.
12. + cells from patients with HTLV-I-associated myelopathy. Tohoku J Exp Med. 1996;179(4):227-235.
13. Higuchi MK, Nagasawa T, Horiuchi M, Oike YI, Yasukawa M, Niho Y. Membrane tumor necrosis factor-alpha (TNF-alpha) expressed on HTLV-I-infected T cells mediates a costimulatory signal for B cell activation-characterization of membrane TNF-alpha. Clin Immunol Immunopathol. 1997;82(2):133-143.
14. Sun SC, Yamaoka S. Activation of NF-kappaB by HTLV-I and implications for cell transformation. Oncogene. 2005;24(39):5952-5964. (Pubitemid 43086113)
15. Franchini G, Fukumoto R, Fullen JR. T-cell control by human T-cell leukemia/lymphoma virus type 1. Int J Hematol. 2003;78(4):280-296. (Pubitemid 37532383)
16. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4(6):586-593.
17. Kannagi M, Sugamura K, Sato H, Okochi K, Uchino H, Hinuma Y. Establishment of human cytotoxic T cell lines specific for human T-cell leukemia /lymphotropic virus type I (HTLV-I). J Immunol. 1983;130(6):2942-2946. (Pubitemid 13107736)
18. Bangham CRM. The immune control and cell-to-cell spread of human T-lymphotropic virus type I. J Gen Virol. 2003;84(Pt 12):3177-89.
19. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7(1):19-30.
20. Romani e Romani N, Gruner S, et al. Proliferating dendritic cell progenitors in human blood. J Exp Med. 1994;180(1):83-93.
21. Makino M, Wakamatsu S, Shimokubo S, Arima N, Baba M. Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. Virology. 2000;274(1):140-148.
22. Mostoller K, Norbury CC, Jain P, Wigdahl B. Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation. J Neurovirol. 2004;10(6):358-71. (Pubitemid 40109623)
23. Jain P, Ahuja J, Khan ZK, et al. Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1. J Leukoc Biol. 2007;82(1):44-56. (Pubitemid 47026415)
24. Tateno M, Kondo N, Itoh T, Chubachi T, Togashi T, Yoshiki T. Rat lymphoid cell lines with human T cell leukemia virus production, I: biological and serological characterization. J Exp Med. 1984;159(4):1105-1116.
25. Sallusto F, Lazanvecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med. 1994;179(4):1109-1118.
26. Makino M, Shimokubo S, Wakamatsu S-I, Izumo S, Baba M. The role of human t-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J Virol. 1999;73(6):4575-4581. (Pubitemid 29246715)
27. Macatonia SE, Cruickshank JK, Rudge P, Knight SC. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Res Hum Retroviruses. 1992;8(9):1699-1706.
28. Koyanagi Y, Itoyama Y, Nakamura N, et al. In vivo infection of human T-cell leukemia virus type I in non-T cells. Virology. 1993;196(1):25-33.
29. Jones KS, Petrow-Sadowski C, Huang YK, Bertolette DC, Ruscetti FW. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat Med. 2008;14(4):429-436.
30. Azakami K, Sato T, Araya N, et al. Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. Blood. 2009;114(15):3208-3215.
31. Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schäkel K. The CD16(+) (FcγRIII+) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med. 2002;196(4):517-527.
32. + blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A. 1996;93(6):2588-2592.
33. Al-Dahoodi ZM, Takemoto S, Kataoka S, Taguchi H. Dysfunction of dendritic and T cells as the cause of immune suppression in HTLV-I infected individuals. J Clin Exp Hematopathol. 2003;43(2):43-48.
34. Kuroda Y, Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol. 1993;42(2):223-226. (Pubitemid 23045894)
35. Nakamura S, Nagano I, Yoshioka M, Shimazaki S, Onodera J, Kogure K. Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy. J Neuroimmunol. 1993;42(2):127-130.
36. Umehara F, Izumo S, Ronquillo AT, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994;53(1):72-77. (Pubitemid 24022089)
37. Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol. 2000;1(6):510-514.
38. Nishimoto N, Yoshizaki K, Eiraku N, et al. Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci. 1990;97(2-3):183-193.
39. Brito Melo GEA, Peruhype-Magalhães V, Teixeira-Carvalho A, et al. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection. Clin Exp Immunol. 2007;147(1):35-44.
40. Hishizawa M, Imada K, Kitawaki T, Ueda M, Kadowaki N, Uchiyama T. Depletion and impaired interferon-alpha-producing capacity of blood plasmacytoid dendritic cells in human T-cell leukaemia virus type I-infected individuals. Br J Haematol. 2004;125(5):568-575.
41. Almeida M, Cordeiro M, Almeida J, Orfao A. Different subsets of peripheral blood dendritic cells show distinct phenotypic and functional abnormalities in HIV-1 infection. AIDS. 2005;19(3):261-271. (Pubitemid 40396557)
42. Ozaki Y, Amakawa R, Ito T, et al. Alteration of peripheral blood dendritic cells in patients with primary Sjögren's syndrome. Arthritis Rheum. 2001;44(2):419-431. (Pubitemid 32207036)
43. Ali A, Patterson S, Cruickshank K, Rudge P, Dalgleish AG, Knight SC. Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1): enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol. 1993;94(1):32-7.
44. Manuel SL, Schell TD, Acheampong E, Rahman S, Khan ZK, Jain P. Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease. J Leukoc Biol. 2009;86(5):1205-16.
45. Donaghy H, Gazzard B, Gotch F, Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood. 2003;101(11):4505-11.
46. Kattan T, MacNamara A, Rowan AG, et al. The avidity and lytic efficiency of the CTL response to HTLV-1. J Immunol. 2009;182(9):5723-5729.
47. Bangham CRM. CTL quality and the control of human retroviral infections. Eur J Immunol. 2009;39(7):1700-1712.
48. Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CRM. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 2008;111(10):5047-5053.
49. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol. 2002;23(9):445-449.
50. Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 2006;108(5):1435-1440.